US 8466290
STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient
granted A61KA61K31/4709A61P
Quick answer
US patent 8466290 (STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient) held by Pharmadesign, Inc. expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pharmadesign, Inc.
- Grant date
- Tue Jun 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/4709, A61P, A61P19/02, A61P29/00